RPID Similar Chart Price Prediction
The price of RPID is predicted to go up -11.24%, based on the high correlation periods with LEVI. The similarity of these two price pattern on the periods is 95.07%.
RPID
LEVI
Down: -11.24%Similarity: 95.07%
RPID Revenue Forecast
RPID EPS Forecast
RPID FAQs
What is RPID revenue forecast for next quarter？
What is RPID eps forecast for next quarter？
RPID Analyst's Forecast
Paul Knight
Keybanc
Buy
2025-02-12
Price Target
$8
Upside
+145.4%
KeyBanc initiated coverage of Rapid Micro Biosystems with an Overweight rating and $8 price target. The analyst believes Rapid Micro's Microbial Growth Direct System is "changing the paradigm" in biological manufacturing quality control. The system is more accurate and provides digital results in three to five days versus manual methods in 5-14 days, the analyst tells investors in a research note. KeyBanc says Rapid Micro is gaining wide adoption in the biopharmaceutical industry that will increase sales visibility and improve margins.
